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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S142cartilage destruction in vitro. These effects are not mediated by the inhi-
bition of histone deacetylases or the induction of the Nrf2 transcription
factor but likely act via NFkB signalling. We are currently pursuing these
ﬁndings in vivo.
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HDAC1, 2 AND 7 AS MODULATORS OF PROTEOGLYCAN PRODUCTION:
THE EFFECTS OF SEPARATE AND SIMULTANEOUS KNOCKDOWN
R. Bakker 1, J.E. Bekkers 1, A.H. Kragten 1, D.B. Saris 1,2, W.J. Dhert 1,3,
L.B. Creemers 1, L.A. Vonk 1. 1UMC Utrecht, Utrecht, Netherlands; 2MIRA
Inst., Univ. of Twente, Enschede, Netherlands; 3Vet. Med., Univ. of Utrecht,
Utrecht, Netherlands
Purpose: Histone deacetylases (HDACs) regulate gene expression by
histone modiﬁcation. HDAC1, 2 and 7 expression is increased in OA
patients and they are associated with downregulation of several chon-
drogenic genes and increased matrix metalloproteinase-13 expression.
Therefore, this study investigated histone deacetylase knockdown as
a possible target to modulate cartilage metabolism.
Methods: OA chondrocytes were obtained from patients undergoing knee
arthroplasty. At passage 2, OA chondrocytes were transfected with siRNA
against HDAC1, 2, and 7 or a mock, or they were treated with the isotype-
selective HDAC inhibitor mocetinostat. Chondrocytes were reverse-trans-
fected during seeding at high density (1.26*106 cells per cm2) on collagen-
coated culture inserts in a 96-wells transwell system. Real-time PCR was
performed to examine gene expression levels of HDAC1, 2 and 7, aggrecan
(ACAN), type I collagen (COL1A1), type II collagen (COL2A1) and matrix
metallopeptidase 13 (MMP13). HDAC1, 2 and 7 were analyzed at the
protein level by Western blot. Glycosaminoglycan (GAG) and DNA content
were determined using a DMMB and Picogreen assay, respectively.
Results: Expression levels of the targeted HDAC were decreased by RNAi.
No differences were observed in GAG and DNA content between the
chondrocytes transfected with mock and HDAC1, 2 or 7-directed siRNA.
Transfection with HDAC1, 2 or 7 siRNA showed no effects on gene
expression levels of ACAN, COL1A1, COL2A1 and MMP13. Knockdown of
HDAC1 resulted in signiﬁcantly higher HDAC2 gene expression levels and
a trend towards higher HDAC7 gene expression levels. Knockdown of
HDAC2 increased HDAC1 and HDAC7 gene expression levels and knock-
down of HDAC7 resulted in increased HDAC1 and HDAC2 gene expression
levels. Transfection with HDAC1, 2, and 7 siRNA together, and treatment
with the isotype-selective HDAC inhibitor mocetinostat increased the
amount of GAG produced by the cells.
Conclusions: Speciﬁc knockdown of HDAC 1, 2 or 7 did not improve the
GAG production by OA chondrocytes, most likely due to the compensatory
upregulation of the other HDAC subtypes. Hence, HDAC 1, 2 and 7 seem to
have overlapping functions in modulating the GAG production of chon-
drocytes. Knockdown of HDAC1, 2 and 7 together did increase GAG
production. This suggests that modulation of multiple HDACs, is necessary
for gene-based treatment of OA.
276
ACTIVATION OF NF-kB/P65 INITIATES CHONDROGENIC
DIFFERENTIATION OF CHONDROPROGENITOR CELLS
M.J. Caron 1, P.J. Emans 1, D.A. Surtel 1, A. Cremers 1, J.-W. Voncken 2,
T.J. Welting 1, L.W. van Rhijn 1. 1Dept. Orthopaedic Surgery, Maastricht
Univ. Med. Ctr., Maastricht, Netherlands; 2Dept. Molecular Genetics,
Maastricht Univ. Med. Ctr., Maastricht, Netherlands
Purpose: For the purpose of cartilage and bone regenerative techniques,
the initiation of chondrogenic differentiation from progenitor cells is an
important and precarious step that must be well-guided. NF-kB/p65 is
reported to be involved in regulation of chondrogenic differentiation.
However, whether it is involved in the initiation of chondrogenesis and its
relation to key chondrogenic transcription factor Sox9 and is poorly
understood. We hypothesized that the early onset of chondrogenic
differentiation is initiated by transient NF-kB/p65 signaling.
Methods: The role of NF-kB/p65 in early chondrogenesis was investigated
in different chondrogenic models: ATDC5 cells, hBMSCs, chicken periosteal
explants and mouse growth plates. NF-kB/p65 activation was manipulatedusing pharmacological inhibitors, RNAi and activating agents. Gene
expression and protein expression analyses, and (immuno)histochemical
stainings were employed to determine the role of NF-kB/p65 in early
chondrogenesis.
Results: All of the employed chondrogenic models showed that early
chondrogenic differentiation correlates with transient activation of NF-kB/
p65 and expression of its transcriptional targets (e.g. COX-2, TNFa, iNOS).
This early NF-kB/p65-mediated signaling leads to early transient expres-
sion of Sox9 and determines the subsequent chondrogenic outcome
(Col2a1 and Col10a1). Subtle stimulation of NF-kB/p65 activity resulted in
increased expression of cartilaginousmarkers in both our in vitro as well as
periosteal explant cultures, even in the absence of known chondrogenic
growth factors. In addition, early NF-kB/p65 activity and Sox9 expression
were enhanced by BMP-2, providing a possible explanation for BMP-2
driven chondrogenic differentiation.
Conclusions: The herein presented data demonstrate that NF-kB/p65
signaling, as well as its intensity and timing, represents one of the tran-
scriptional regulatory mechanisms of the chondrogenic developmental
program of chondroprogenitor cells. Importantly, this conceptmay be used
as a molecular tool to modulate chondrogenic differentiation and thereby
improve the success of cartilage regenerative techniques.
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COG5 INHIBITION INDUCES GLYCOSYLATION DEFECTS AFFECTING
CHONDROGENESIS AND INTERFERING WITH WNT, BUT NOT BMP
SIGNALING
F. Cailotto, F.P. Luyten, R.J. Lories. Katholieke Univ.it Leuven, Leuven, Belgium
Purpose: Osteoarthritis (OA) is a highly disabling pathology of the bone-
cartilage unit, to which both patient-dependent (weight excess, trauma.)
and genetic factors contribute. Recently, a locus on Chromosome 7 (7q22)
was linked to knee and hand OA by genome wide association study. In this
locus, the Conserved oligomeric Golgi complex subunit (COG) 5 gene
encodes a component of Golgi apparatus. Mutations in COG5 are associ-
ated with mild congenital glycosylation disorders, and COG5 expression is
higher in 3D than in monolayer cultures of articular chondrocytes. As
aspects of endochondral bone formation are recapitulated in OA (loss of
stable phenotype, hypertrophy), we investigated the role of COG5 in
chondrogenesis.
Methods: We used the ATDC5 chondrogenic cell line. Three independent
stable clonal colonies of each, control (empty vector) and COG5 knocked-
down cells (COG5-), were selected over 7 days (D) using puromycin. Clones
were cultured as high density micromasses (2x105 cells/10 ml) to mimic
the condensation step of developing cartilage in vivo. Chondrogenesis was
induced by culturing cells for 14 D in DMEM/F12 + 5% FBS, supplemented
with ITS [insulin (10 mg/ml), transferrin (10 mg/ml) and sodium selenite (30
nM)]. On D14, cells were switched to mineralization medium (aMEM + 5%
FBS, supplemented with ITS) to investigate the mineralization phase of
chondrogenesis. mRNA expression of typical chondrogenesis markers
(Aggrecan (Agg), type II (Col2a1) and X (Col10a1)) collagens were assessed
by quantitative RT-PCR. Likely, we assessed mRNA expression of Wnts (-4,
-5a, -5b, -11) and BMPs (-2, -4, -6, -7). Quantiﬁcation of Alcian Blue,
Safranin O, Sirius red and Alizarin red staining were used to evaluate
proteoglycans, collagens and mineralized content respectively. Western
blot was used to check the glycosylation status of Wnts, and the activation
status of Smad 1/5/8, typically increased in the proliferative phase of
chondrogenesis. Cell viability was checked with Live/Dead assay.
Results: During the early proliferation (D1-7) and late proliferation/
hypertrophy phase (D7-14), Col2a1 and Agg mRNA were strongly
increased, but to a lesser extent in COG5-. Safranin O and alcian blue
staining were also less upregulated in COG5-. Pro-chondrogenic BMP-4
increased, and was surprisingly signiﬁcantly higher in COG5-. This was
consistent with a higher activation of Smad 1/5/8 in COG5-.Wnt-4, -5a and
-5b mRNA increases were similar in control and COG5- cells. BMP-6 and
Col10a1 mRNA were increased at D14, but signiﬁcantly lower in COG5-.
A strongWnt-11mRNA increasewas observed at D7-14 in controls, but not
in COG5-. Moreover, analysis of Wnt-5a in culture supernatants revealed
a glycosylation defect in COG5-. Sirius red increased over time, and was
signiﬁcantly higher in controls. However, no differencewas detected in cell
viability. During mineralization phase (D14 to D21), BMP-2 and -7 mRNA
